These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8780381)

  • 21. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype.
    Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW
    Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
    Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
    Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
    J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
    Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
    Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin expression and usage by prostate cancer cell lines on laminin substrata.
    Edlund M; Miyamoto T; Sikes RA; Ogle R; Laurie GW; Farach-Carson MC; Otey CA; Zhau HE; Chung LW
    Cell Growth Differ; 2001 Feb; 12(2):99-107. PubMed ID: 11243469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.
    Collett GP; Betts AM; Johnson MI; Pulimood AB; Cook S; Neal DE; Robson CN
    Clin Cancer Res; 2000 Aug; 6(8):3241-8. PubMed ID: 10955810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors.
    Droz D; Patey N; Paraf F; Chrétien Y; Gogusev J
    Lab Invest; 1994 Nov; 71(5):710-8. PubMed ID: 7526040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers.
    Takahashi S; Suzuki S; Inaguma S; Ikeda Y; Cho YM; Hayashi N; Inoue T; Sugimura Y; Nishiyama N; Fujita T; Chao J; Ushijima T; Shirai T
    Prostate; 2003 Feb; 54(3):187-93. PubMed ID: 12518323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
    Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
    Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate.
    Knox JD; Cress AE; Clark V; Manriquez L; Affinito KS; Dalkin BL; Nagle RB
    Am J Pathol; 1994 Jul; 145(1):167-74. PubMed ID: 8030747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of MCP-3 and BRCA2 mRNA expression levels by beta(1) integrins.
    Moro L; Fornaro M; Steger CA; Languino LR
    Exp Mol Pathol; 2001 Jun; 70(3):239-47. PubMed ID: 11418002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective down-regulation of integrin receptors in spheroids of squamous cell carcinoma.
    Waleh NS; Gallo J; Grant TD; Murphy BJ; Kramer RH; Sutherland RM
    Cancer Res; 1994 Feb; 54(3):838-43. PubMed ID: 8306347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast.
    Zutter MM; Mazoujian G; Santoro SA
    Am J Pathol; 1990 Oct; 137(4):863-70. PubMed ID: 2221016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical analysis of rasGTPase activating protein (rasGAP) in prostate cancer.
    Davidson B; Agulansky L; Goldberg I; Friedman E; Ramon J; Barshack I; Kopolovic J
    Pathol Res Pract; 1998; 194(6):399-404. PubMed ID: 9689648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional regulation of the beta1C integrin splice variant in human prostate adenocarcinoma.
    Moro L; Greco M; Ditonno P; Battaglia M; Marra E; Perlino E
    Int J Oncol; 2003 Dec; 23(6):1601-6. PubMed ID: 14612932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.